132 related articles for article (PubMed ID: 32810510)
21. The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol.
Albayrak G; Korkmaz FD; Tozcu D; Dogan Turacli I
J Cell Biochem; 2019 Jun; 120(6):10564-10571. PubMed ID: 30628735
[TBL] [Abstract][Full Text] [Related]
22. Systematic screening of synthetic organochalcogen compounds with anticancer activity using human lung adenocarcinoma spheroids.
Batista JEDS; Rodrigues MB; Bristot IJ; Silva V; Bernardy S; Rodrigues OED; Dornelles L; Carvalho FB; de Sousa FJF; Fernandes MDC; Zanatta G; Soares FAA; Klamt F
Chem Biol Interact; 2024 Jun; 396():111047. PubMed ID: 38735454
[TBL] [Abstract][Full Text] [Related]
23. VDAC1 Mediated Anticancer Activity of Gallic Acid in Human Lung Adenocarcinoma A549 Cells.
Maimaiti A; Aili A; Kuerban H; Li X
Anticancer Agents Med Chem; 2018; 18(2):255-262. PubMed ID: 28901260
[TBL] [Abstract][Full Text] [Related]
24. Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
Zhuang X; Qiao T; Xu G; Yuan S; Zhang Q; Chen X
Oncol Rep; 2016 Oct; 36(4):2200-6. PubMed ID: 27498922
[TBL] [Abstract][Full Text] [Related]
25. [Effects of heme oxygenase-1 knockdown on proliferation, invasion and metastasis of lung adenocarcinoma A549 cells and its mechanism].
Cao L; Suo XJ; Jiang W; Zhao D; Yan XJ; Yang J; Ma ZY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):813-819. PubMed ID: 31770847
[No Abstract] [Full Text] [Related]
26. Etomidate Suppresses Invasion and Migration of Human A549 Lung Adenocarcinoma Cells.
Chu CN; Wu KC; Chung WS; Zheng LC; Juan TK; Hsiao YT; Peng SF; Yang JL; Ma YS; Wu RS; Chung JG
Anticancer Res; 2019 Jan; 39(1):215-223. PubMed ID: 30591461
[TBL] [Abstract][Full Text] [Related]
27. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
[TBL] [Abstract][Full Text] [Related]
28. T-type Ca
Sallán MC; Visa A; Shaikh S; Nàger M; Herreros J; Cantí C
Cancer Res; 2018 Feb; 78(3):603-609. PubMed ID: 29343521
[TBL] [Abstract][Full Text] [Related]
29. Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts.
El Alaoui C; Chemin J; Fechtali T; Lory P
PLoS One; 2017; 12(10):e0186864. PubMed ID: 29073181
[TBL] [Abstract][Full Text] [Related]
30. Elevation of sensitivity to anticancer agents of human lung adenocarcinoma A549 cells by knockdown of claudin-2 expression in monolayer and spheroid culture models.
Maruhashi R; Akizuki R; Sato T; Matsunaga T; Endo S; Yamaguchi M; Yamazaki Y; Sakai H; Ikari A
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):470-479. PubMed ID: 29247669
[TBL] [Abstract][Full Text] [Related]
31. T-type calcium channels are involved in hypoxic pulmonary hypertension.
Chevalier M; Gilbert G; Roux E; Lory P; Marthan R; Savineau JP; Quignard JF
Cardiovasc Res; 2014 Sep; 103(4):597-606. PubMed ID: 25016616
[TBL] [Abstract][Full Text] [Related]
32. T-type calcium channel antagonism decreases motivation for nicotine and blocks nicotine- and cue-induced reinstatement for a response previously reinforced with nicotine.
Uslaner JM; Vardigan JD; Drott JM; Uebele VN; Renger JJ; Lee A; Li Z; Lê AD; Hutson PH
Biol Psychiatry; 2010 Oct; 68(8):712-8. PubMed ID: 20579972
[TBL] [Abstract][Full Text] [Related]
33. Aryl Hydrocarbon Receptor Mediates Cell Proliferation Enhanced by Benzo[a]pyrene in Human Lung Cancer 3D Spheroids.
Jimma Y; Jimma K; Yachi M; Hakata S; Habano W; Ozawa S; Terashima J
Cancer Invest; 2019; 37(8):367-375. PubMed ID: 31462083
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of PAR-1 Receptor Signaling by Enoxaparin Reduces Cell Proliferation and Migration in A549 Cells.
Alturkistani A; Ghonem N; Power-Charnitsky VA; Pino-Figueroa A; Migliore MM
Anticancer Res; 2019 Oct; 39(10):5297-5310. PubMed ID: 31570424
[TBL] [Abstract][Full Text] [Related]
35. Identification of KvLQT1 K+ channels as new regulators of non-small cell lung cancer cell proliferation and migration.
Girault A; Privé A; Trinh NT; Bardou O; Ferraro P; Joubert P; Bertrand R; Brochiero E
Int J Oncol; 2014 Mar; 44(3):838-48. PubMed ID: 24366043
[TBL] [Abstract][Full Text] [Related]
36. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
Li J; Zhang W; Xia H; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
[TBL] [Abstract][Full Text] [Related]
37. Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
An J; Xue Y; Long M; Zhang G; Zhang J; Su H
Oncotarget; 2017 Jun; 8(24):39230-39240. PubMed ID: 28424406
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro.
Chen XQ; Wang YL; Li ZY; Lin TY
Mol Med Rep; 2014 Jul; 10(1):347-52. PubMed ID: 24788469
[TBL] [Abstract][Full Text] [Related]
39. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
[TBL] [Abstract][Full Text] [Related]
40. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
